Medifast (MED) Gross Profit (2010 - 2026)

Medifast (MED) has 17 years of Gross Profit data on file, last reported at $51.8 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 38.56% year-over-year to $51.8 million; the trailing twelve-month figure through Mar 2026 stood at $242.7 million (down 39.56% YoY), and the FY2025 full-year result was $275.2 million, down 38.11% from the prior year.
• Gross Profit for Q1 2026 stood at $51.8 million, down from $52.1 million in the prior quarter.
• Across five years, Gross Profit topped out at $321.7 million in Q2 2022 and bottomed at $51.8 million in Q1 2026.
• The 5-year median for Gross Profit is $127.3 million (2024), against an average of $158.1 million.
• The widest annual swing landed in 2022, when Gross Profit advanced 21.62%; it then slumped 48.34% in 2024.
• A 5-year view of Gross Profit shows it stood at $233.6 million in 2022, then plunged by 39.48% to $141.4 million in 2023, then tumbled by 37.6% to $88.2 million in 2024, then plunged by 40.9% to $52.1 million in 2025, then slipped by 0.74% to $51.8 million in 2026.
• The last three Gross Profit figures came in at $51.8 million (Q1 2026), $52.1 million (Q4 2025), and $62.2 million (Q3 2025), per Business Quant data.

Peer Comparison